- Home
- NGL vs RGNX Comparison
NGL vs RGNX Comparison
Compare NGL & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGL
- RGNX
- Stock Information
- Founded
- NGL 1940
- RGNX 2008
- Country
- NGL United States
- RGNX United States
- Employees
- NGL N/A
- RGNX N/A
- Industry
- NGL Natural Gas Distribution
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NGL Utilities
- RGNX Health Care
- Exchange
- NGL Nasdaq
- RGNX Nasdaq
- Market Cap
- NGL 751.7M
- RGNX 661.2M
- IPO Year
- NGL 2011
- RGNX 2015
- Fundamental
- Price
- NGL $9.85
- RGNX $11.61
- Analyst Decision
- NGL
- RGNX Strong Buy
- Analyst Count
- NGL 0
- RGNX 7
- Target Price
- NGL N/A
- RGNX $30.29
- AVG Volume (30 Days)
- NGL 460.9K
- RGNX 533.2K
- Earning Date
- NGL 11-04-2025
- RGNX 11-06-2025
- Dividend Yield
- NGL N/A
- RGNX N/A
- EPS Growth
- NGL N/A
- RGNX N/A
- EPS
- NGL N/A
- RGNX N/A
- Revenue
- NGL $3,250,313,000.00
- RGNX $161,318,000.00
- Revenue This Year
- NGL N/A
- RGNX $198.02
- Revenue Next Year
- NGL N/A
- RGNX $2.67
- P/E Ratio
- NGL N/A
- RGNX N/A
- Revenue Growth
- NGL N/A
- RGNX 91.30
- 52 Week Low
- NGL $2.64
- RGNX $5.04
- 52 Week High
- NGL $10.29
- RGNX $13.93
- Technical
- Relative Strength Index (RSI)
- NGL 80.26
- RGNX 50.12
- Support Level
- NGL $6.30
- RGNX $10.80
- Resistance Level
- NGL $6.50
- RGNX $12.05
- Average True Range (ATR)
- NGL 0.49
- RGNX 0.68
- MACD
- NGL 0.27
- RGNX -0.17
- Stochastic Oscillator
- NGL 90.32
- RGNX 29.76
About NGL NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests
NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.